Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Vaccines, Synthetic"" wg kryterium: Temat


Tytuł:
Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools.
Autorzy:
da Silva MK; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Campos DMO; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Akash S; Department of Pharmacy, Daffodil International University, Sukrabad, Dhaka 1207, Bangladesh.
Akter S; Bangladesh Council of Scientific & Industrial Research (BCSIR), Dhaka 1205, Bangladesh.
Yee LC; Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Kota Bharu 11800, Kelantan, Malaysia.
Fulco UL; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Oliveira JIN; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Oct 21; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*/prevention & control
Humans ; COVID-19 Vaccines ; Vaccinology/methods ; Proteomics ; mRNA Vaccines ; Vaccines, Synthetic
Czasopismo naukowe
Tytuł:
In Ovo Vaccination with Recombinant Herpes Virus of the Turkey-Laryngotracheitis Vaccine Adjuvanted with CpG-Oligonucleotide Provides Protection against a Viral Challenge in Broiler Chickens.
Autorzy:
Gaghan C; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Browning M; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Fares AM; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Abdul-Careem MF; Health Research Innovation Center 2C58, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Gimeno IM; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Kulkarni RR; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Oct 17; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Herpesvirus 1, Gallid*/physiology
Herpesviridae Infections*/prevention & control
Herpesviridae Infections*/veterinary
Viral Vaccines*
Poultry Diseases*
Animals ; Chickens ; Adjuvants, Vaccine ; Vaccination/veterinary ; Vaccines, Synthetic ; Herpesvirus 1, Meleagrid/genetics ; Turkeys
Czasopismo naukowe
Tytuł:
Herpes Virus Infections in Kidney Transplant Patients (HINT) - a prospective observational cohort study.
Autorzy:
Hamm SR; Viro-Immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Saini SK; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
Hald A; Viro-Immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Vaaben AV; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
Pedersen NW; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
Suarez-Zdunek MA; Viro-Immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Harboe ZB; Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, North Zealand, Hillerød, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Bruunsgaard H; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Johansen IS; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Larsen CS; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Bistrup C; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nephrology, Odense University Hospital, Odense, Denmark.
Birn H; Department of Renal Medicine, Aarhus University Hospital, and Departments of Clinical Medicine and Biomedicine, Aarhus University, Aarhus, Denmark.
Sørensen SS; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Nephrology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Hadrup SR; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
Nielsen SD; Viro-Immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. .; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. .; Department of Surgical Gastroenterology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Oct 16; Vol. 23 (1), pp. 687. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Herpes Zoster*/epidemiology
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*
Kidney Transplantation*/adverse effects
Aged ; Humans ; Herpesvirus 3, Human ; Prospective Studies ; Vaccines, Synthetic
Czasopismo naukowe
Tytuł:
Intranasal administration with recombinant vaccine PRVXJ-delgE/gI/TK-S induces strong intestinal mucosal immune responses against PDCoV.
Autorzy:
Huang B; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Huang Y; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Deng L; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Xu T; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Jian Z; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Lai S; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.; Key Laboratory of Animal Diseases and Human Health of Sichuan Province, Chengdu, 611130, China.
Ai Y; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.; Key Laboratory of Animal Diseases and Human Health of Sichuan Province, Chengdu, 611130, China.
Zhu L; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China. .; Key Laboratory of Animal Diseases and Human Health of Sichuan Province, Chengdu, 611130, China. .
Xu Z; College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.; Key Laboratory of Animal Diseases and Human Health of Sichuan Province, Chengdu, 611130, China.
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2023 Sep 23; Vol. 19 (1), pp. 171. Date of Electronic Publication: 2023 Sep 23.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/veterinary
Swine Diseases*/prevention & control
Animals ; Mice ; Swine ; Immunity, Mucosal ; Administration, Intranasal/veterinary ; Vaccines, Synthetic ; Intestines ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Assessment of the Immunoprotective Efficacy of Recombinant 14-3-3 Protein and Dense Granule Protein 10 (GRA10) as Candidate Antigens for Rabbit Vaccines against Eimeria intestinalis .
Autorzy:
Xiong C; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
He W; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Xiao J; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Hao G; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Pu J; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Chen H; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Xu L; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Zhu Y; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Yang G; Department of Parasitology, College of Veterinary, Sichuan Agricultural University, Chengdu 611130, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 22; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 22.
Typ publikacji:
Journal Article
MeSH Terms:
Eimeria*
Protozoan Vaccines*
Coccidiosis*/prevention & control
Coccidiosis*/veterinary
Poultry Diseases*/prevention & control
Animals ; Rabbits ; 14-3-3 Proteins ; Cytokines ; Oocysts ; Vaccines, Synthetic ; Weight Gain ; Chickens
Czasopismo naukowe
Tytuł:
Efficacy of a synthetic peptide Chlamydia pecorum major outer membrane protein vaccine in a wild koala (Phascolarctos cinereus) population.
Autorzy:
Simpson SJ; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, 2006, Australia. .
Higgins DP; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, 2006, Australia.
Timms P; Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, QLD, 4556, Australia.
Mella VSA; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, 2006, Australia.
Crowther MS; School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, 2006, Australia.
Fernandez CM; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, 2006, Australia.
McArthur C; School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, 2006, Australia.
Phillips S; Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, QLD, 4556, Australia.
Krockenberger MB; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, 2006, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 12; Vol. 13 (1), pp. 15087. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial, Veterinary; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer Vaccines*
Phascolarctidae*
Psittacosis*
Animals ; Australia ; Membrane Proteins ; Peptides ; Vaccines, Subunit ; Vaccines, Synthetic
SCR Organism:
Chlamydia pecorum
Czasopismo naukowe
Tytuł:
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines.
Autorzy:
Gupta S; Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Pellett S; Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Pokaż więcej
Źródło:
Toxins [Toxins (Basel)] 2023 Sep 08; Vol. 15 (9). Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
COVID-19*/prevention & control
Toxins, Biological*
Humans ; Pandemics ; Vaccines, Attenuated ; Vaccines, Synthetic ; Bacterial Vaccines ; Tetanus Toxoid
Czasopismo naukowe
Tytuł:
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).
Autorzy:
Jeewandara C; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Fernando S; Ministry of Health Sri Lanka, Colombo, Sri Lanka.
Pushpakumara PD; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Ramu ST; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Kamaladasa A; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Gunasekara B; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Aberathna IS; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Kuruppu H; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Ranasinghe T; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Dayarathne S; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Dissanayake O; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Gamalath N; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Ekanayake D; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Jayamali J; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Wijesinghe A; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Dissanayake M; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Somathilake G; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Harvie M; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Danasekara S; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Jayathilaka D; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka.
Wijayatilake HDK; Ministry of Health Sri Lanka, Colombo, Sri Lanka.
Weerasooriya N; Ministry of Health Sri Lanka, Colombo, Sri Lanka.
Kekulandara C; Ministry of Health Sri Lanka, Colombo, Sri Lanka.
Schimanski L; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
Tan TK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
Dong T; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
Townsend A; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
Ogg GS; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
Malavige GN; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Nugegoda, Sri Lanka. .; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Feb 02; Vol. 12 (1), pp. 1727. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunization*
Immunogenicity, Vaccine*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
ChAdOx1 nCoV-19/*administration & dosage
SARS-CoV-2/*immunology
Vaccines, Synthetic/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme 2/immunology ; Biomarkers/blood ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/immunology ; ChAdOx1 nCoV-19/immunology ; Female ; Humans ; Interferon-gamma/metabolism ; Lymphocytes/immunology ; Lymphocytes/metabolism ; Lymphocytes/virology ; Male ; Middle Aged ; Seroconversion ; Time Factors ; Treatment Outcome ; Vaccines, Synthetic/immunology ; Young Adult
Czasopismo naukowe
Tytuł:
Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
Autorzy:
Wisnewski AV; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Liu J; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Lucas C; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Klein J; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Iwasaki A; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Cantley L; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Fazen L; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Campillo Luna J; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Slade M; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Redlich CA; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jan 18; Vol. 17 (1), pp. e0262657. Date of Electronic Publication: 2022 Jan 18 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
COVID-19/*immunology
COVID-19 Vaccines/*immunology
SARS-CoV-2/*immunology
Vaccines, Synthetic/*immunology
mRNA Vaccines/*immunology
Angiotensin-Converting Enzyme 2/chemistry ; Angiotensin-Converting Enzyme 2/immunology ; COVID-19/prevention & control ; COVID-19 Vaccines/administration & dosage ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Vaccines, Synthetic/administration & dosage ; mRNA Vaccines/administration & dosage
Czasopismo naukowe
Tytuł:
Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice.
Autorzy:
Shin M; College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Kim K; College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Lee HJ; College of Biological Sciences, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Lee R; College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Jung YJ; College of Biological Sciences, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Park J; College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea. .
Hahn TW; College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 13; Vol. 12 (1), pp. 660. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunity, Cellular*
Immunity, Humoral*
Vaccines, Synthetic*
Baculoviridae/*immunology
Immunocompetence/*immunology
Viral Envelope Proteins/*immunology
Viral Envelope Proteins/*physiology
Viral Vaccines/*immunology
Zika Virus/*immunology
Zika Virus Infection/*immunology
Zika Virus Infection/*virology
Animals ; Male ; Mice, Inbred C57BL ; Mice
Czasopismo naukowe
Tytuł:
Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine.
Autorzy:
Zheng X; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Institute of Systems Genetics, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xu H; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yi X; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zhang T; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Wei Q; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li H; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ai J; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. .; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2021 Dec 06; Vol. 20 (1), pp. 160. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*immunology
Antigens, Neoplasm/*immunology
Cancer Vaccines/*immunology
Prostatic Neoplasms/*immunology
Vaccines, Synthetic/*immunology
mRNA Vaccines/*immunology
Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Biomarkers, Tumor ; Cancer Vaccines/therapeutic use ; Computational Biology/methods ; Epitope Mapping ; Gene Expression Profiling ; Gene Regulatory Networks ; Humans ; Male ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Reproducibility of Results ; Transcriptome ; Vaccines, Synthetic/therapeutic use ; mRNA Vaccines/therapeutic use
Raport
Tytuł:
To fight Lyme disease, vaccine targets ticks.
Autorzy:
Wadman M
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2021 Nov 19; Vol. 374 (6570), pp. 925. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji:
Wiadomości
MeSH Terms:
Lyme Disease Vaccines*
Vaccines, Synthetic*
Arachnid Vectors/*immunology
Ixodes/*immunology
Lyme Disease/*prevention & control
Tick Bites/*immunology
Animals ; Arachnid Vectors/physiology ; Humans ; Ixodes/physiology ; Lyme Disease/transmission ; mRNA Vaccines
Periodyk
Tytuł:
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines.
Autorzy:
Lucchese G; Department of Neurology, Medical University of Greifswald, 17475 Greifswald, Germany.
Jahantigh HR; Interdisciplinary Department of Medicine-Section of Occupational Medicine, University of Bari, 70124 Bari, Italy.; Animal Health and Zoonosis Doctoral Program, Department of Veterinary Medicine, University of Bari, 70010 Bari, Italy.
De Benedictis L; Interdisciplinary Department of Medicine-Section of Occupational Medicine, University of Bari, 70124 Bari, Italy.
Lovreglio P; Interdisciplinary Department of Medicine-Section of Occupational Medicine, University of Bari, 70124 Bari, Italy.
Stufano A; Interdisciplinary Department of Medicine-Section of Occupational Medicine, University of Bari, 70124 Bari, Italy.; Animal Health and Zoonosis Doctoral Program, Department of Veterinary Medicine, University of Bari, 70010 Bari, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Jul 27; Vol. 13 (8). Date of Electronic Publication: 2021 Jul 27.
Typ publikacji:
Journal Article
MeSH Terms:
Epitopes/*chemistry
HTLV-I Infections/*prevention & control
Human T-lymphotropic virus 1/*immunology
RNA, Messenger/*chemistry
Vaccines, Subunit/*immunology
Vaccines, Synthetic/*immunology
Viral Vaccines/*immunology
mRNA Vaccines/*immunology
Amino Acid Sequence ; Databases, Genetic ; Epitope Mapping ; Epitopes/genetics ; Epitopes/immunology ; HTLV-I Infections/immunology ; HTLV-I Infections/virology ; Human T-lymphotropic virus 1/chemistry ; Human T-lymphotropic virus 1/genetics ; Humans ; Immunization ; RNA, Messenger/genetics ; RNA, Messenger/immunology ; Vaccines, Subunit/chemistry ; Vaccines, Subunit/genetics ; Vaccines, Synthetic/chemistry ; Vaccines, Synthetic/genetics ; Viral Vaccines/chemistry ; Viral Vaccines/genetics ; mRNA Vaccines/chemistry ; mRNA Vaccines/genetics
Czasopismo naukowe
Tytuł:
Protection of Teleost Fish against Infectious Diseases through Oral Administration of Vaccines: Update 2021.
Autorzy:
Bøgwald J; Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT-The Arctic University of Norway, Muninbakken 21, N-9019 Tromsø, Norway.
Dalmo RA; Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT-The Arctic University of Norway, Muninbakken 21, N-9019 Tromsø, Norway.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 10; Vol. 22 (20). Date of Electronic Publication: 2021 Oct 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Fish Diseases/*prevention & control
Vaccines, Synthetic/*administration & dosage
Administration, Oral ; Animals ; Fish Diseases/immunology ; Immunity, Mucosal ; Parasitic Diseases, Animal/immunology ; Parasitic Diseases, Animal/prevention & control ; Vaccines, DNA/administration & dosage ; Vaccines, DNA/immunology ; Vaccines, Synthetic/immunology ; Vibrio Infections/immunology ; Vibrio Infections/prevention & control ; Vibrio Infections/veterinary ; Virus Diseases/immunology ; Virus Diseases/prevention & control ; Virus Diseases/veterinary
Czasopismo naukowe
Tytuł:
Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history.
Autorzy:
McDade TW; Northwestern University, 1810 Hinman Avenue, Evanston, IL, 60208, USA. .
Demonbreun AR; Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
Sancilio A; Northwestern University, 1810 Hinman Avenue, Evanston, IL, 60208, USA.
Mustanski B; Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
D'Aquila RT; Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
McNally EM; Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Aug 30; Vol. 11 (1), pp. 17325. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Angiotensin-Converting Enzyme 2/*metabolism
Antibodies, Neutralizing/*analysis
COVID-19/*prevention & control
SARS-CoV-2/*immunology
Vaccines, Synthetic/*administration & dosage
Adult ; Antibodies, Neutralizing/metabolism ; Antibodies, Viral/analysis ; Antibodies, Viral/metabolism ; COVID-19/immunology ; COVID-19/metabolism ; COVID-19 Nucleic Acid Testing ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Female ; Humans ; Immunoglobulin G/analysis ; Immunoglobulin G/metabolism ; Male ; Middle Aged ; Spike Glycoprotein, Coronavirus/metabolism ; Time Factors ; Vaccination ; Vaccines, Synthetic/immunology ; Young Adult ; mRNA Vaccines
Czasopismo naukowe
Tytuł:
Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates.
Autorzy:
van Doremalen N; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Fischer RJ; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Schulz JE; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Holbrook MG; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Smith BJ; Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Lovaglio J; Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Petsch B; CureVac AG, 72076 Tuebingen, Germany.
Munster VJ; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Aug 19; Vol. 13 (8). Date of Electronic Publication: 2021 Aug 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Immunization, Secondary*
Immunogenicity, Vaccine*
Antibodies, Viral/*blood
COVID-19 Vaccines/*immunology
SARS-CoV-2/*immunology
Vaccines, Synthetic/*immunology
Animals ; Antibodies, Neutralizing/blood ; COVID-19 Vaccines/administration & dosage ; Immunity, Cellular ; Immunization Schedule ; Macaca mulatta ; Male ; Spike Glycoprotein, Coronavirus/immunology ; T-Lymphocytes/immunology ; Vaccines, Synthetic/administration & dosage ; mRNA Vaccines
Czasopismo naukowe
Tytuł:
The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development.
Autorzy:
Zahmanova G; Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.; Department of Technology Transfer and IP Management, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
Takova K; Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.
Tonova V; Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.
Koynarski T; Department of Animal Genetics, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria.
Lukov LL; Faculty of Sciences, Brigham Young University-Hawaii, Laie, HI 96762, USA.
Minkov I; Department of Technology Transfer and IP Management, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.; Institute of Molecular Biology and Biotechnologies, 4108 Markovo, Bulgaria.
Pishmisheva M; Department of Infectious Diseases, Pazardzhik Multiprofile Hospital for Active Treatment, 4400 Pazardzhik, Bulgaria.
Kotsev S; Department of Infectious Diseases, Pazardzhik Multiprofile Hospital for Active Treatment, 4400 Pazardzhik, Bulgaria.
Tsachev I; Department of Microbiology, Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria.
Baymakova M; Department of Infectious Diseases, Military Medical Academy, 1606 Sofia, Bulgaria.
Andonov AP; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 16; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 16.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis E virus*
Hepatitis E*/epidemiology
Hepatitis E*/prevention & control
Viral Vaccines*
Animals ; Humans ; Female ; Swine ; Pregnancy ; Rabbits ; Rats ; Sheep ; Europe/epidemiology ; Persistent Infection ; Vaccines, Synthetic ; Zoonoses
Czasopismo naukowe
Tytuł:
AB 5 -Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus.
Autorzy:
Ahn J; The Interdisciplinary Graduate Program in Integrative Biotechnology & Translational Medicine, Yonsei University, Incheon 21983, Republic of Korea.
Yu JE; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of Korea.
Kim H; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of Korea.
Sung J; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of Korea.
Han G; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of Korea.; Department of Integrated OMICS for Biomedical Science, WCU Program of Graduate School, Yonsei University, Seoul 03722, Republic of Korea.
Sohn MH; Department of Pediatrics, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.
Seong BL; Department of Microbiology, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.; Vaccine Innovative Technology ALliance (VITAL)-Korea, Yonsei University, Seoul 03721, Republic of Korea.
Pokaż więcej
Źródło:
Toxins [Toxins (Basel)] 2023 Jun 29; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Encephalitis Virus, Japanese*/genetics
Animals ; Mice ; Antibodies, Viral ; Escherichia coli/genetics ; Antibodies, Neutralizing ; Vaccines, Synthetic/genetics ; Cholera Toxin/genetics ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
Allergen-specific immunotherapy by recombinant Der P1 allergen-derived peptide-based vaccine in an allergic mouse model.
Autorzy:
Asoudeh Moghanloo S; Department of Molecular Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran.; Immunology, Asthma and Allergy Research Institute (IAARI), Tehran University of Medical Sciences, Tehran, Iran.
Forouzanfar M; Department of Molecular Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran.
Jafarinia M; Department of Molecular Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran.
Fazlollahi MR; Immunology, Asthma and Allergy Research Institute (IAARI), Tehran University of Medical Sciences, Tehran, Iran.
Kardar GA; Immunology, Asthma and Allergy Research Institute (IAARI), Tehran University of Medical Sciences, Tehran, Iran.; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Jun; Vol. 11 (6), pp. e878.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Allergens*
Hypersensitivity*/therapy
Animals ; Mice ; Mice, Inbred BALB C ; Interleukin-4 ; Interleukin-13 ; Vaccines, Synthetic ; Desensitization, Immunologic ; Vaccines, Subunit ; Peptides ; Cytokines ; Immunoglobulin E
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies